{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:04:52Z","timestamp":1728965092880},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75833-z","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T06:01:44Z","timestamp":1728626504000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Side effects associated with homogenous and heterogenous doses of Oxford\u2013AstraZeneca vaccine among adults in Bangladesh: an observational study"],"prefix":"10.1038","volume":"14","author":[{"given":"Nadim","family":"Sharif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubayet Rayhan","family":"Opu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tama","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsana","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshari A.","family":"Alsuwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos O.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annia A.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid J.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pablo","family":"Miramontes-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuvra Kanti","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"75833_CR1","unstructured":"Mathieu, E. et al. Coronavirus pandemic (COVID-19). Our world in data. (2024). https:\/\/ourworldindata.org\/coronavirus"},{"key":"75833_CR2","unstructured":"COVID - Coronavirus Statistics. Worldometers. (2024). https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"75833_CR3","unstructured":"World Health Organization (WHO). (2024). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines"},{"key":"75833_CR4","unstructured":"List of Prequalified Vaccines. World Health Organization (WHO). (2024). https:\/\/extranet.who.int\/prequal\/vaccines\/list-prequalified-vaccines"},{"key":"75833_CR5","doi-asserted-by":"publisher","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","volume":"12","author":"N Sharif","year":"2021","unstructured":"Sharif, N., Alzahrani, K. J., Ahmed, S. N. & Dey, S. K. Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front. Immunol. 12, 714170 (2021).","journal-title":"Front. Immunol."},{"key":"75833_CR6","unstructured":"COVID-19 Vaccination Dashboard for Bangladesh. (2024). https:\/\/dashboard.dghs.gov.bd\/pages\/covid19-vaccination-update.php"},{"key":"75833_CR7","first-page":"1","volume":"30","author":"HA Mushtaq","year":"2022","unstructured":"Mushtaq, H. A. et al. A review of adverse effects of COVID-19 vaccines. Le Infezioni Med. 30, 1 (2022).","journal-title":"Le Infezioni Med."},{"key":"75833_CR8","doi-asserted-by":"publisher","first-page":"2140364","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty, A. L. et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw. open. 4, 2140364\u20132140364 (2021).","journal-title":"JAMA Netw. open."},{"key":"75833_CR9","doi-asserted-by":"publisher","first-page":"e0260287","DOI":"10.1371\/journal.pone.0260287","volume":"16","author":"N Sharif","year":"2021","unstructured":"Sharif, N. et al. Protective measures are associated with the reduction of transmission of COVID-19 in Bangladesh: a nationwide cross-sectional study. PLoS One. 16, e0260287 (2021).","journal-title":"PLoS One"},{"key":"75833_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41541-021-00336-1","volume":"6","author":"I McDonald","year":"2021","unstructured":"McDonald, I., Murray, S. M., Reynolds, C. J., Altmann, D. M. & Boyton, R. J. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines. 6, 74 (2021).","journal-title":"npj Vaccines"},{"key":"75833_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/vaccines10030427","volume":"10","author":"MM Patwary","year":"2022","unstructured":"Patwary, M. M. et al. COVID-19 vaccine acceptance among low-and lower-middle-income countries: a rapid systematic review and meta-analysis. Vaccines. 10, 427 (2022).","journal-title":"Vaccines"},{"key":"75833_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/vaccines8030482","volume":"8","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 8, 482 (2020).","journal-title":"Vaccines"},{"key":"75833_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/vaccines10010110","volume":"10","author":"CS Shakeel","year":"2022","unstructured":"Shakeel, C. S., Mujeeb, A. A., Mirza, M. S., Chaudhry, B. & Khan, S. J. Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines. 10, 110 (2022).","journal-title":"Vaccines"},{"key":"75833_CR14","doi-asserted-by":"crossref","unstructured":"Kaplan, R. M. & Milstein, A. Influence of a COVID-19 vaccine\u2019s effectiveness and safety profile on vaccination acceptance. Proc. Natl. Acad. Sci. 118, e2021726118 (2021).","DOI":"10.1073\/pnas.2021726118"},{"key":"75833_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/01410768211013437","volume":"114","author":"A Majeed","year":"2021","unstructured":"Majeed, A., Papaluca, M. & Molokhia, M. Assessing the long-term safety and efficacy of COVID-19 vaccines. J. Roy Soc. Med. 114, 337\u2013340 (2021).","journal-title":"J. Roy Soc. Med."},{"key":"75833_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/10410236.2023.2171951","volume":"39","author":"A Sendra","year":"2024","unstructured":"Sendra, A., Torkkola, S. & Parviainen, J. AstraZeneca vaccine controversies in the media: theorizing about the mediatization of ignorance in the context of the COVID-19 vaccination campaign. Health Commun. 39, 541\u2013551 (2024).","journal-title":"Health Commun."},{"key":"75833_CR17","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1038\/s41598-024-54450-w","volume":"14","author":"K Mirnia","year":"2024","unstructured":"Mirnia, K. et al. Short-term side effects of COVID-19 vaccines among healthcare workers: a multicenter study in Iran. Sci. Rep. 14, 4086 (2024).","journal-title":"Sci. Rep."},{"key":"75833_CR18","doi-asserted-by":"crossref","unstructured":"Nguyen, S. V. et al. Side effects following first dose of COVID-19 vaccination in Ho Chi Minh City, Vietnam. Hum. Vaccines Immunother. 21760 66 (2023). (2023).","DOI":"10.1080\/21645515.2023.2176066"},{"key":"75833_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/vaccines9060674","volume":"9","author":"A Alhazmi","year":"2021","unstructured":"Alhazmi, A. et al. Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines. 9, 674 (2021).","journal-title":"Vaccines"},{"key":"75833_CR20","doi-asserted-by":"publisher","first-page":"876336","DOI":"10.3389\/fpubh.2022.876336","volume":"10","author":"S Ganesan","year":"2022","unstructured":"Ganesan, S. et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE\u2014an observational study. Front. Public. Health. 10, 876336 (2022).","journal-title":"Front. Public. Health"},{"key":"75833_CR21","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1002\/jmv.27708","volume":"94","author":"G Arora","year":"2022","unstructured":"Arora, G. et al. Adverse events and breakthrough infections associated with COVID-19 vaccination in the Indian population. J. Med. Virol. 94, 3147\u20133154 (2022).","journal-title":"J. Med. Virol."},{"key":"75833_CR22","first-page":"e21809","volume":"14","author":"A Chakraborty","year":"2022","unstructured":"Chakraborty, A., Reval, N. & Kamath, L. Adverse events following COVID-19 vaccination in selected apartments in Bangalore, India. Cureus. 14, e21809 (2022).","journal-title":"Cureus"},{"key":"75833_CR23","first-page":"100207","volume":"12","author":"M Mohsin","year":"2022","unstructured":"Mohsin, M. et al. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: a cross-sectional study. Vaccine: X. 12, 100207 (2022).","journal-title":"Vaccine: X"},{"key":"75833_CR24","unstructured":"Seyed Alinaghi, S. et al. Safety and adverse events related to COVID-19 mRNA vaccines; a systematic review. Arch. acad. Emerg. med. 10, e41 (2022)."},{"key":"75833_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/vaccines11020231","volume":"11","author":"J Aldali","year":"2022","unstructured":"Aldali, J., Meo, S. A. & Al-Khlaiwi, T. Adverse effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 vaccines among the adult population in Saudi Arabia: a cross-sectional study. Vaccines. 11, 231 (2022).","journal-title":"Vaccines"},{"key":"75833_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaip.2022.12.010","volume":"11","author":"A Judd","year":"2023","unstructured":"Judd, A. et al. Urticaria after COVID-19 vaccination and vaccine hesitancy. J. Allergy Clin. Immunol. Pract. 11, 958 (2023).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"75833_CR27","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00228-022-03399-8","volume":"78","author":"N Ben-Fredj","year":"2022","unstructured":"Ben-Fredj, N. et al. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation. Eur. J. Clin. Pharmacol. 78, 1959\u20131964 (2022).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"75833_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40257-022-00721-z","volume":"23","author":"PC Wu","year":"2022","unstructured":"Wu, P. C. et al. New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review. Am. J. Clin. Dermatol. 23, 775\u2013799 (2022).","journal-title":"Am. J. Clin. Dermatol."},{"key":"75833_CR29","first-page":"S165","volume":"10","author":"PK Wulandari","year":"2022","unstructured":"Wulandari, P. K. et al. Adverse effects of Third-Dose Moderna Vaccination for Healthcare Workers of Udayana University Hospital, Bali, Indonesia. Int. J. Med. Stud. 10, S165\u2013S165 (2022).","journal-title":"Int. J. Med. Stud."},{"key":"75833_CR30","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/vaccines9111326","volume":"9","author":"M Tobaiqy","year":"2021","unstructured":"Tobaiqy, M., MacLure, K., Elkout, H. & Stewart, D. Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines. 9, 1326 (2021).","journal-title":"Vaccines"},{"key":"75833_CR31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12879-022-07411-5","volume":"22","author":"E Babaee","year":"2022","unstructured":"Babaee, E. et al. Adverse effects following COVID-19 vaccination in Iran. BMC Infect. Dis. 22, 476 (2022).","journal-title":"BMC Infect. Dis."},{"key":"75833_CR32","doi-asserted-by":"publisher","first-page":"n1114","DOI":"10.1136\/bmj.n1114","volume":"373","author":"A Potteg\u00e5rd","year":"2021","unstructured":"Potteg\u00e5rd, A. et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. Bmj. 373, n1114 (2021).","journal-title":"Bmj"},{"key":"75833_CR33","doi-asserted-by":"publisher","first-page":"n699","DOI":"10.1136\/bmj.n699","volume":"372","author":"J Wise","year":"2021","unstructured":"Wise, J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. Bmj. 372, n699 (2021).","journal-title":"Bmj"},{"key":"75833_CR34","first-page":"e37275","volume":"15","author":"TT Favas","year":"2023","unstructured":"Favas, T. T. et al. Thrombotic and thromboembolic complications after vaccination against COVID-19: a systematic review. Cureus. 15, e37275 (2023).","journal-title":"Cureus"},{"key":"75833_CR35","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0140-6736(21)00762-5","volume":"397","author":"SD \u00d8stergaard","year":"2021","unstructured":"\u00d8stergaard, S. D., Schmidt, M., Horv\u00e1th-Puh\u00f3, E., Thomsen, R. W. & S\u00f8rensen, H. T. Thromboembolism and the Oxford\u2013AstraZeneca COVID-19 vaccine: side-effect or coincidence? Lancet. 397, 1441\u20131443 (2021).","journal-title":"Lancet"},{"key":"75833_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12959-022-00370-6","volume":"20","author":"CV John","year":"2022","unstructured":"John, C. V. et al. Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India. Thromb. J. 20, 11 (2022).","journal-title":"Thromb. J."},{"key":"75833_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni, C. et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect. Dis. 21, 939\u2013949 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"75833_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1473-3099(22)00146-3","volume":"22","author":"C Menni","year":"2022","unstructured":"Menni, C. et al. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Lancet Infect. Dis. 22, 1002\u20131010 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"75833_CR39","first-page":"e23526","volume":"14","author":"IM Dighriri","year":"2022","unstructured":"Dighriri, I. M. et al. Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: a systematic review. Cureus. 14, e23526 (2022).","journal-title":"Cureus"},{"key":"75833_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/vaccines10010109","volume":"10","author":"MO Elgendy","year":"2022","unstructured":"Elgendy, M. O. et al. Side effects and efficacy of COVID-19 vaccines among the Egyptian population. Vaccines. 10, 109 (2022).","journal-title":"Vaccines"},{"key":"75833_CR41","first-page":"e36005","volume":"15","author":"F Khan","year":"2023","unstructured":"Khan, F. et al. Side effects of COVID-19 vaccines among diabetic subjects and healthy individuals. Cureus. 15, e36005 (2023).","journal-title":"Cureus"},{"key":"75833_CR42","doi-asserted-by":"publisher","first-page":"2252239","DOI":"10.1080\/21645515.2023.2252239","volume":"19","author":"S d\u2019Almeida","year":"2023","unstructured":"d\u2019Almeida, S. et al. Thromboembolism after Astra Zeneca COVID-19 vaccine: not always PF4-antibody mediated. Hum. Vaccines Immunother. 19, 2252239 (2023).","journal-title":"Hum. Vaccines Immunother"},{"key":"75833_CR43","doi-asserted-by":"publisher","first-page":"1222868","DOI":"10.3389\/fpubh.2023.1222868","volume":"11","author":"N Sharif","year":"2023","unstructured":"Sharif, N. et al. Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh. Front. Public. Health. 11, 1222868 (2023).","journal-title":"Front. Public. Health"},{"key":"75833_CR44","doi-asserted-by":"publisher","first-page":"102148","DOI":"10.1016\/j.dsx.2021.05.021","volume":"15","author":"N Sharif","year":"2021","unstructured":"Sharif, N. et al. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: a nationwide study amid the second wave. Diabetes Metab. Syndr. Clin. Res. Rev. 15, 102148 (2021).","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"75833_CR45","unstructured":"Guidance for industry. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. (2021). https:\/\/www.fda.gov\/media\/73679\/download"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75833-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T10:10:03Z","timestamp":1728900603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75833-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75833-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23794"}}